#13 – The Role of A.I. in Healthcare

Introduction

In the newest episode of the “H1 AI” podcast, host Ariel Katz welcomes guests Craig Lipset, Founder at Clinical Innovation Partners, and Angela Radcliffe, Founder at How We Mighty Ventures. The trio discusses the groundbreaking influence of Artificial Intelligence in clinical trials, offering unique insights into its future in healthcare.

AI’s Potential in Clinical Trials

Angela Radcliffe shares her perspectives on the realistic expectations and promising future of AI in healthcare, focusing on how to effectively integrate AI with crucial data.

Addressing Adoption Barriers

Craig Lipset highlights the healthcare industry’s hesitant approach towards adopting AI. He emphasizes the need for acknowledging and embracing AI’s practical applications to accelerate its integration.

Ensuring Patient-Centricity Amidst Technological Advances

The conversation underscores the importance of maintaining patient focus in the era of AI. Both guests agree on the necessity of balancing technological progress with human-centric healthcare approaches.

Real-world Applications of AI

Insights into AI’s current role in enhancing operational aspects of drug development are shared, showcasing its impact on study design, site selection, and patient recruitment.

Predicting AI’s Future in Clinical Trials

The episode concludes with projections about AI’s evolving role in clinical trials, anticipating significant advancements in efficiency and decision-making processes.

Conclusion

This “H1 AI” episode offers a rich exploration of AI’s present and future role in clinical trials, with expert insights from Katz, Lipset, and Radcliffe.